IDH1 and glioblastoma: These findings highlight that wild-type IDH-1, in coordination with the regulation of PHDs and the activity of the CCT complex, integrates metabolic processes, hypoxic response, and oxidative stress management, thereby contributing to the progression and survival of GBM cells.